Survival analysis demonstrated that elevated TFAP2A expression correlates with poorer overall survival, suggesting its potential as a prognostic marker in non-small cell lung cancer (Figure 4D). This evidence concerns the gene TFAP2A and non-small cell lung carcinoma.